Malignant Catarrhal Fever: Understanding Molecular Diagnostics in Context of Epidemiology by Li, Hong et al.
Int. J. Mol. Sci. 2011, 12, 6881-6893; doi:10.3390/ijms12106881 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Review 
Malignant Catarrhal Fever: Understanding Molecular 
Diagnostics in Context of Epidemiology  
Hong Li 
1,2,*, Cristina W. Cunha 
1 and Naomi S. Taus 
1,2 
1  Animal Disease Research Unit, USDA-Agricultural Research Service, Washington State University, 
Pullman, WA 99164, USA; E-Mails: cwcunha@vetmed.wsu.edu (C.W.C.); 
tausns@vetmed.wsu.edu (N.S.T.) 
2  Department of Veterinary Microbiology and Pathology, Washington State University, Pullman,  
WA 99164, USA 
*  Author to whom correspondence should be addressed; E-Mail: hli@vetmed.wsu.edu;  
Tel.: +509-335-6002; Fax: +509-335-8328. 
Received: 24 August 2011; in revised form: 22 September 2011 / Accepted: 10 October 2011 /  
Published: 18 October 2011 
 
Abstract:  Malignant  catarrhal  fever  (MCF)  is  a  frequently  fatal  disease,  primarily  of 
ruminants, caused by a group of gammaherpesviruses. Due to complexities of pathogenesis 
and epidemiology in various species, which are either clinically-susceptible or reservoir 
hosts, veterinary clinicians face significant challenges in laboratory diagnostics. The recent 
development of specific assays for viral DNA and antibodies has expanded and improved 
the inventory of laboratory tests and opened new opportunities for use of MCF diagnostics. 
Issues related to understanding and implementing appropriate assays for specific diagnostic 
needs must be addressed in order to take advantage of molecular diagnostics in the laboratory.  
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1. Introduction 
Malignant catarrhal fever (MCF) is a clinically dramatic and often lethal infection of many species 
of Bovidae  and Cervidae [1–3] caused by  a member of the MCF virus (MCFV)  group [2,4] that 
belongs to the genus Macavirus in the subfamily Gammaherpesvirinae [2,4]; these viruses exist in 
nature as inapparent infections in well adapted hosts. Currently, 10 members within the MCFV group 
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have been identified,  and six of them are clearly  associated with clinical disease [4]. Alcelaphine 
herpesvirus 1 (AlHV-1) and ovine herpesvirus 2 (OvHV-2) are the major causative agents responsible 
for  wildebeest-associated  MCF  (WA-MCF)  and  sheep-associated  MCF  (SA-MCF),  respectively. 
AlHV-1 is endemic in wildebeest, in which it is a subclinical infection [5]. Domestic and wild sheep 
are reservoirs for OvHV-2 [3]. Other MCFVs known to cause disease include caprine herpesvirus-2 
(CpHV-2), which is endemic in goats [6,7], an MCFV of unknown origin causing disease in white-tailed 
deer (MCFV-WTD) [8,9], ibex MCFV (MCFV-ibex) carried by ibex [10], and an AlHV-2-like virus 
carried by Jackson hartebeest [11]. The remaining four viruses carried by roan antelope [12], oryx, 
muskox [10], and aoudad [4] have not yet been associated with disease. MCF is increasingly being 
recognized as the cause of significant economic losses in several major ruminant species [13–15], as 
well as a threat to certain other susceptible species held in mixed-species confinement [16–18]. Due to 
the complexities of pathogenesis and its epidemiology, clinicians and veterinarians face significant 
challenges  in  diagnosing  MCFV  infection  and/or  disease.  However,  recently  developed  molecular 
diagnostic  assays  have  improved  the  detection  and  differentiation  of  MCF  causative  viruses,  and 
increased  accuracy  of  laboratory  assays  in  confirming  MCFV  infection  and/or  disease  in  various 
species. Understanding the appropriate application of newly developed MCFV diagnostic assays for 
each  epidemiological  situation  is  necessary  to  take  advantage  of  these  molecular  diagnostics.  The 
situational application of MCFV diagnostics in veterinary diagnostic laboratories is the focus of this 
mini review. 
2. Infection, Disease and Clinical Epidemiology 
Malignant catarrhal fever occurs in clinically susceptible hosts, such as cattle, bison, deer and pigs 
when a sufficient dose of an MCFV is transmitted from a reservoir host. Disease usually has an acute 
onset and involves a spectrum of symptoms that may include corneal opacity, profuse ocular and nasal 
discharge,  diarrhea,  enlarged  lymph  nodes,  fever  and  anorexia.  The  distribution  of  lesions  differs 
slightly depending upon the species affected but the basic pathological features are consistent and 
include widespread lymphoproliferation, vasculitis, and epithelial necrosis [19–23]. The transmitting 
viral dose does not affect lesion severity once clinical MCF develops [24]; however, transmitting viral 
dose is significantly correlated with the incubation period and the timing of first viral DNA detection 
by  polymerase  chain  reaction  (PCR)  in  peripheral  blood  leukocytes  (PBL)  [25].  Both  clinical 
presentation  and  pathological  features  are  of  significant  diagnostic  value  [21].  Detection  of  viral  
DNA  by  PCR  in  PBL  and  tissues,  especially  at  high  levels,  can  support  the  diagnosis  of  MCFV  
caused disease [26]. 
Experimental studies in cattle, bison and sheep indicate that the susceptibility of various ruminant 
species to OvHV-2 infection and MCF varies significantly. Bison are approximately 1000 times more 
susceptible to clinical MCF than cattle [14,27]. The difference in susceptibility to MCF between bison 
and domestic sheep is more than six orders of magnitude [24,28]. Although MCF is usually fatal once 
clinical signs develop, especially in bison, cattle and certain species of deer, subclinical infection can 
occur. Subclinical infections with an MCF group virus in bison and other species, such as deer and 
cattle,  have  been  documented  [29–31].  For  instance,  a  prospective  study  using  300  healthy  bison 
showed that 23.7% of the bison (71/300) were antibody-positive for MCF group viruses and 11.3% (8/71) Int. J. Mol. Sci. 2011, 12   6883 
 
of  the  antibody-positive  animals had detectable  OvHV-2  DNA in  the peripheral blood by  PCR [21]. 
Recent  experimental  infection  of  cattle  and  bison  with  OvHV-2  by  aerosol  transmission  further 
confirms that clinically susceptible hosts can be subclinically infected [24,27]. 
MCF may occur wherever a reservoir host is present and there are clinically susceptible animals in 
close proximity. The epidemiology of MCF, regarding the pattern of virus transmission from reservoir 
hosts to clinically susceptible hosts, has been relatively well defined for AlHV-1 and OvHV-2, the two 
major  MCFVs  [1–3].  Both  viruses  are  shed  into  the  environment  via  nasal,  and  perhaps  ocular, 
secretions  from  their  reservoirs  [32,33].  Clinically-susceptible  species  acquire  the  virus  through 
inhalation, although ingestion of virus-laden secretions from contaminated foodstuffs or water has also 
been  suggested  as  a  route  of  transmission  [34].  Efficient  transmission  via  infected  secretions  is 
enhanced by close contact and by a cool, moist environment; however, long distance transmission has 
been documented [35]. MCFV is not transmitted by natural means from one clinically-susceptible host 
to another; affected animals are dead-end hosts [2,14,36]. Virtually all reservoir hosts are infected with 
their  own  distinct  MCFV;  however,  a  dual  infection  can  occur  under  certain  conditions  [6].  The 
infection in reservoir hosts is usually subclinical, although MCF-like disease has been rarely reported 
in sheep and goats [28,37]. 
The  epidemiology  of  AlHV-1  and  OvHV-2  within  their  natural  hosts  has  been  relatively  well 
defined,  and  differs  significantly  from  each  other  [1,2].  The  epidemiology  within  the  wildebeest 
species involves both horizontal and vertical transmission. A portion of wildebeest calves are born 
infected  through  the  transplacental  route;  however,  most  calves  are  infected  horizontally  from 
previously infected cohorts. Intense viral shedding from the wildebeest occurs predominantly during 
the first 90 days of life through ocular and nasal secretions [32,38]. Neutralizing antibody develops by 
about 3 months of age, after which viral shedding declines dramatically [32]. Adult wildebeest shed a 
relatively  low  level  of  the  virus,  except  during  periods  of  stress  or  parturition  [38,39].  
Wildebeest-associated MCF occurs seasonally with wildebeest calving [40], and the virus originates 
from the wildebeest calves up to the age of about 4 months [32,41]. 
The epidemiology of OvHV-2 within sheep has become better understood. Although lambs can be 
infected at an early age [42], similar to wildebeest calves, the majority of lambs are not infected until 
after 2 months of age, under natural flock conditions [43]. If lambs are removed from contact with 
infected  sheep  prior  to  that  age,  they  remain  uninfected  and  can  be  raised  virus  free  [44].  This 
knowledge  is  being  used  by  sheep  producers  and  zoos [16]  to  produce  OvHV-2-free  sheep.  Data 
support the concept of delayed, rather than congenital or perinatal, infection of lambs with OvHV-2. 
The delayed infection in lambs is largely due  to the viral dose at first exposure [45], rather than  
age-related susceptibility or passive-immune protection [46]. Both adolescent lambs and adult sheep 
shed virus predominantly though nasal secretions [33]. Lambs between 6 and 9 months of age shed 
virus more frequently and intensively than at any other stage of life. No correlation between parturition 
and  virus  shedding  levels  in  adult  sheep  has  been  found  [33],  suggesting  that  the  likelihood  of 
transmission from adult sheep is relatively stable and low year-round; therefore, the small increase of 
SA-MCF in spring during lambing season could reflect factors other than viral shedding levels, such as 
climate conditions and seasonal variations in stock densities that could influence exposure intensity. 
Little  is  known  concerning  epidemiology  of  other  viruses  in  the  MCFV  group.  Based  on 
phylogenetic analysis of a portion of the DNA polymerase gene that is relatively conserved among Int. J. Mol. Sci. 2011, 12   6884 
 
herpesviruses  [4],  all  MCFVs  identified  to  date  can  be  clustered  into  two  major  groups:  (1)  the 
Alcelaphinae/Hippotraginae  group,  which  includes  AlHV-1,  AlHV-2,  hippotragine  herpesvirus  1 
(HiHV-1), and the MCFV carried by oryx; and 2) the Caprinae group including OvHV-2, CpHV-2, 
MCFV-WTD,  and  the  MCFVs  carried  by  ibex,  muskox,  and  aoudad  [4].  These  data  suggest  the 
epidemiology of these viruses within the groups may be similar. The viruses within the group share 
certain biological properties; for example, the viruses in the Alcelaphinae/Hippotraginae group can 
propagate in cell culture, and a recent study on CpHV-2 transmission among goats showed that CpHV-2 
has a similar transmission pattern as OvHV-2 [47]. 
It is important to note that naturally occurring MCF in multiple-species mixed operations, such as 
zoos, state fairs, wildlife parks and  game farms, is linked to the reservoir hosts: goats have been 
responsible for CpHV-2 induced MCF in sika deer [48,49], also white-tailed deer [50], and pronghorn 
antelopes [51]; and ibex have been responsible for several cases of MCF in bongo [52] and an anoa [53]. 
With the complexity of multiple-species environments, confirmation of MCFV caused disease and 
differentiation of a causative virus not only requires accurate diagnostic tools, but also epidemiological 
information. 
3. Serological Tests 
Several serological assays have been developed for detection of antibodies against MCFVs, and all 
the assays use the alcelaphine herpesviruses as antigens, predominantly AlHV-1, because these viruses 
can be propagated in vitro. These assays include virus neutralization (VN), immunoblotting, enzyme-linked 
immunosorbent assay (ELISA)/competitive-inhibition ELISA (cELISA), immunofluorescence assay 
(IFA)/immunoperoxidase test (IPT), and complement fixation test [54–60]. These tests can be divided 
into  three  categories:  neutralizing  antibody-,  polyclonal  antibody-  and  monoclonal  antibody-based 
assays. Viral neutralization tests have been developed for detection of antibodies to AlHV-1 or other 
viruses in the Alcelaphinae/Hippotraginae group of both reservoir and clinically-affected hosts [61]. 
The VN tests are highly specific and work well for detection of infected wildebeest or other related 
hosts, such as hartebeest and topi. Infected sheep usually develop no or low neutralizing antibody 
responses to AlHV-1 [62]; therefore, the viral neutralization test is of very limited use in detection of 
antibodies in animals infected with OvHV-2 or the other related viruses carried by Caprinae species. 
Polyclonal antibody-based assays, including ELISA, IFA, and IPT among others, detect antibodies 
against  multiple  epitopes  of  AlHV-1.  Generally,  these  tests  have  good  sensitivity,  but  reduced 
specificity, due to cross-reactivity with other herpesviruses, such as bovine herpesviruses 1 and 4 [63,64]. 
To  increase  specificity,  a  cELISA  for  detection  of  MCF  viral  antibody  was  developed  using  an 
antibody (15-A) against an epitope conserved among all MCFVs examined to date [58]. The MCF 
cELISA has high specificity and sensitivity due to the use of the monoclonal antibody and its direct 
conjugation with the detecting enzyme [65]. A recent study reported an ELISA using AlHV-1 antigens 
that resulted in good agreement with the cELISA using a set of field bovine serum samples [66]. 
However, the cELISA still offers the advantage of testing samples from many species without the need 
for  species-specific  enzyme-labeled  conjugates  for  each  species  being  tested  [65].  In  addition, 
relatively crude antigens may be used in the cELISA without reducing the desired specificity. Int. J. Mol. Sci. 2011, 12   6885 
 
Serological tests are best used for surveying asymptomatic animals in the field and a positive result 
is indicative of infection. Virtually all reservoir hosts of MCFVs are infected and consistently develop 
antibodies, which can be detected by any of the serological tests. Uninfected lambs under 4 months of 
age may be antibody-positive due to the presence of maternal antibody [43]; therefore, a serological 
test  should  not  be  used  to  determine  the  infection  status  of  a  young  animal,  especially  for  the 
production of MCFV-free animals for mixed-species programs [44]. It is unusual for adult reservoir 
hosts such as sheep and goats to be seronegative. However, young animals less than 12 months of age, 
especially in a small flock or herd, may test antibody negative due to exposure to a low collective virus 
dose shed from infected animals [45]. An animal challenged with a low dose of virus may take more 
than 4 weeks to become seropositive [67], which should be considered when serology is used to test an 
animal  in  pre-shipment  or  quarantine  procedures.  Additionally,  animals  from  specially-designed 
programs  intended  to  produce  MCF-free  animals,  or  from  zoos,  small  operations,  or  other 
environments where the animals are separated at an early age from an infected flock or herd and hand 
raised are expected to be seronegative to MCF antibodies. Overall, serology is reliable for determining 
infection status in adult reservoir hosts, although it does not differentiate MCFVs. Detection of MCF 
viral antibodies in clinically susceptible species, such as cattle, bison and deer, also indicates infection. 
However, since a significant percentage of these species can be subclincially infected with the virus 
[21,29,30],  the  presence  of  antibody  supports  the  diagnosis  of  disease  only  when  associated  with 
histopathological evidence suggestive of MCF. 
4. Polymerase Chain Reaction (PCR) Assays 
PCR has become an important tool in MCF molecular diagnostics. The first PCR for detection of 
AlHV-1 DNA was reported in 1990 [68] and since then, at least a dozen PCRs in different formats 
have  been  developed  targeting  various  MCFVs  [6,8,69–77].  Among  those,  the  one  with  the  most 
significant impact is the PCR specific for detection of OvHV-2 DNA developed by Baxter et al. [70]. 
This  assay  in  nested  format  was  developed  from  the  base  sequence  of  a  fragment  cloned  from  a 
lymphoblastoid cell line that was derived from an acute case of SA-MCF. The primers target a DNA 
fragment in the ORF 75 of OvHV-2, a gene coding for a viral tegument protein [70]. The specificity 
for OvHV-2 arises from one of the primers (#556), which binds to a region of low homology between 
OvHV-2 and AlHV-1 [70]. This nested PCR has high sensitivity and is validated for detection of 
OvHV-2 DNA in infected sheep as well as in animals with clinical MCF [64,78]. The assay has been 
widely  used  in  veterinary  diagnostic  laboratories;  however,  its  use  as  a  routine  method  to  detect 
OvHV-2 DNA for confirmation of clinical SA-MCF in diagnostic laboratories may be problematic due 
to  a  high  potential  for  amplicon  contamination  leading  to  false  positive  results  in  diagnostic 
laboratories. The second important step in MCF PCR development was a quantitative PCR (qPCR) for 
OvHV-2 DNA developed by Hussy and coworkers [77]. The OvHV-2-specific primer-probe set for the 
real-time qPCR is based on the same sequence of genomic OvHV-2 DNA that had been used for the 
nested PCR (ORF 75 gene) [77] and showed adequate sensitivity for clinical samples [73]. Another 
significant advance in MCF molecular diagnostics, especially for mixed-species operations, such as 
zoos, wildlife parks, and game farms, was the development of a multiplex PCR for detection and 
differentiation of MCFVs known to cause disease [76]. The multiplex PCR is a probe-based real-time Int. J. Mol. Sci. 2011, 12   6886 
 
PCR that targets a polymorphic region in the viral DNA polymerase gene containing unique sequences 
for each pathogenic MCFV of interest [76], and represents a rapid, reliable, and differential method for 
the identification of MCFVs in clinical samples. 
These newly developed assays have significantly improved MCF diagnostics at the molecular level 
and  the  key  question  for  clinicians  and  veterinarians  is:  which  assay  should  be  used?  In  MCF 
diagnostics, it is important to first consider epidemiological information. In most cases, it is clear 
whether the disease is associated with sheep, wildebeest, or another reservoir host, and a test specific 
for the expected virus can be employed. However, when a sample comes from a zoo or game farm 
where  various  reservoir  hosts  may  have  been  in  contact  with  the  clinically  susceptible  species, 
multiplex  PCR  or  several  PCRs  specific  for  different  individual  viruses  should  be  considered.  In 
general, all samples can be divided into two large categories: clinical cases (whether or not the disease 
is caused by an MCFV) and subclinical cases (whether or not an animal is infected with an MCFV). 
Both clinical and subclinical MCFV infections occur in clinically-susceptible hosts, such as cattle, 
bison, and deer. In clinical cases of SA-MCF, levels of OvHV-2 DNA in PBL and tissues are usually 
high, ranging from a thousand to over a million copies per microgram DNA, which can be easily 
detected by the OvHV-2 qPCR [24]. The qPCR is highly recommended for diagnosis of OvHV-2-induced 
MCF. In clinical samples derived from mixed-species operations, the multiplex PCR is recommended 
to confirm which virus is causal [76]. In subclinically infected bison and cattle, levels of OvHV-2 
DNA in PBL are low, and in most cases not detectable even by nested PCR [21]. The confirmation of 
infection in clinically susceptible hosts that are disease-free is usually an irrelevant issue, since the 
subclinical infection leading to clinical MCF in cattle and bison is uncommon, and transmission of the 
virus from an infected animal to its cohorts is unlikely [36,79]. Virtually all reservoir hosts, such as 
sheep, goats and wildebeest, are infected with their respective MCFVs and their infection status can be 
generally  confirmed  by  serology.  There  are  some  instances  where  it  is  necessary  to  use  PCR  to 
document that animals are MCFV-free. For example, in order to raise OvHV-2-free sheep and perform 
an early separation of uninfected lambs from a positive flock, initial screening of lambs requires a PCR 
test [44]. In these cases, it is necessary to use a nested PCR to maximize sensitivity, since the nested 
PCR is more sensitive than the qPCR [26]. Veterinarians or managers in mixed-species operations 
usually  want  to  know  which  MCFV(s)  infect  their  reservoir  species  and  request  PCR  for  that 
identification. One should keep in mind that: (1) some PCR assays may not have adequate sensitivity 
to detect viral DNA in PBL of certain reservoir hosts; for example, CpHV-2 specific PCR detects only 
85% of infected goats that are seropositive; and (2) viral DNA levels in PBL may vary among different 
reservoir species: infected sheep usually have enough viral DNA in their PBL to be detected by PCR, 
while viral DNA in PBL cannot be detected by PCR in most infected oryx [10] or black wildebeest [80]. 
One also should keep in mind that all infected reservoir hosts are considered to be the source for virus 
transmission regardless of which virus the animal carries. Although it is extremely rare, MCF can 
occur in reservoir hosts, which is supported by the experimental induction of MCF in sheep by high 
dose OvHV-2 challenge [28]. In these cases, antibody or PCR testing has little diagnostic value, and 
the verification of suspected cases of MCF in the reservoir species will require additional laboratory 
data (e.g. compatible histological lesions, and ruling out other differential diagnoses). It is necessary to 
keep in mind that an unidentified MCFV can be present in cases with strong clinical and pathological 
indications of MCF, even though all existing PCRs are negative. Although the amplification products Int. J. Mol. Sci. 2011, 12   6887 
 
require verification by sequencing, the degenerate PCR that pan-specifically targets the herpesviral 
DNA polymerase gene [81] is a useful tool to identify new members of the MCFV group, and will 
continue to be used in the MCF diagnostic field. 
5. Other Potential Molecular Diagnostic Tests 
In cases where MCF is suspected in a reservoir host, the use of a diagnostic assay directly targeting 
a viral component that is associated with lesion development would be of great relevance to confirm 
the diagnosis. The in situ PCR specific for OvHV-2 was initially thought to have diagnostic potential [82], 
but it was shown to be technically difficult for adaptation as a routine diagnostic tool. Recent studies 
showed that the OvHV-2 major capsid protein is detected in sheep lung during initial pulmonary viral 
replication [83] and in rabbit tissues with OvHV-2 induced MCF [84]. Further data showed that the 
OvHV-2 ORF 25 gene encoding the major capsid protein was highly expressed in tissues of bison with 
experimentally induced MCF, and levels of the transcripts were significantly co-related with lesion 
severity  [85,86].  These  data  suggest  that  ORF  25  gene  transcripts  and/or  the  capsid  protein  can  
be  a  diagnostic  target  for  OvHV-2  induced  MCF.  Monoclonal  or  monospecific  polyclonal  
antibodies  against  the  OvHV-2  capsid  proteins  can  potentially  be  generated  and  used  in  an 
immunohistochemistry-based assay to provide a definitive confirmation of the disease by detecting 
viral proteins in tissues with lesions. Also, detection of the gene transcripts by reverse-transcriptase 
PCR (RT-PCR) can be an alternative assay. A preliminary study showed that transcripts of the ORF 25 
gene can be detected in the RNA samples obtained from formalin-fixed, paraffin-embedded tissues [87], 
suggesting that real-time RT-PCR may have potential for clinical diagnosis of MCF.  
6. Summary 
Several newly developed molecular diagnostic assays are now available for MCF and due to the 
complexity of pathogenesis and its epidemiology in various species, including clinically-susceptible 
and  reservoir  hosts,  the  challenge  for  clinicians  and  veterinarians  is  to  choose  the  right  test  for 
confirmation of the disease or infection. The broad range of natural hosts for MCFVs can be generally 
divided into two categories: reservoir hosts (such as sheep, goats, and wildebeest) and clinically-susceptible 
hosts (such as cattle, bison, and deer). Virtually all reservoir hosts are infected and serological assays 
are useful and efficient to determine infection status except for very young animals with maternal 
antibodies. Using PCR for detection and differentiation of MCFV in reservoir hosts is generally used 
only for very specific purposes; for example, nested PCR is needed to determine whether lambs are 
free of OvHV-2 in order to establish an OvHV-2-free flock. Serology and PCR have little value for 
confirming the disease in a reservoir host with suspected MCF. Both clinical disease and subclinical 
infection occur in clinically susceptible hosts. Both nested PCR and real-time PCR work well for 
detection of viral DNA in PBLs and tissues of animals with clinical MCF. The use of real-time qPCR 
is  highly  recommended  for  routine  testing  due  to  its  adequate  sensitivity,  high  specificity,  and 
decreased  vulnerability  to  cross  contamination  of  amplicons.  Serological  testing,  specifically  the 
cELISA, is recommended for screening the infection status in clinically susceptible hosts rather than 
PCR, which may result in a high number of false negatives due to low levels of viral DNA in PBLs 
during subclinical infection. It is important to keep in mind that epidemiological information needs to Int. J. Mol. Sci. 2011, 12   6888 
 
be considered first in order to determine which specific PCR should be used to confirm the diagnosis 
of the cause of clinical disease. If samples are from mixed-species operations, the multiplex PCR is the 
first choice, because it saves significant time, labor and cost. In case where the multiplex PCR results 
are  negative,  the  herpesvirus  degenerate  PCR  would  be  the  next  option.  With  the  advances  in 
molecular technologies and better understanding of the disease, a new generation of tests for MCF 
with better sensitivity, specificity, and convenience may be developed in the near future. 
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